期刊
EUROPEAN JOURNAL OF HUMAN GENETICS
卷 20, 期 6, 页码 613-617出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/ejhg.2011.225
关键词
Alzheimer disease; copy number variations; KLK6; MEOX2; SLC30A3; FPR2
资金
- Rouen University Hospital [PHRC GMAJ 2008/067]
Studying rare extreme forms of Alzheimer disease (AD) may prove to be a useful strategy in identifying new genes involved in monogenic determinism of AD. Amyloid precursor protein (APP), PSEN1, and PSEN2 mutations account for only 85% of autosomal dominant early-onset AD (ADEOAD) families. We hypothesised that rare copy number variants (CNVs) could be involved in ADEOAD families without mutations in known genes, as well as in rare sporadic young-onset AD cases. Using high-resolution array comparative genomic hybridisation, we assessed the presence of rare CNVs in 21 unrelated ADEOAD cases, having no alteration on known genes, and 12 sporadic AD cases, with an age of onset younger than 55 years. The analysis revealed the presence of 7 singleton CNVs (4 in ADEOAD and 3 in sporadic cases) absent in 1078 controls and 912 late-onset AD cases. Strikingly, 4 out of 7 rearrangements target genes (KLK6, SLC30A3, MEOX2, and FPR2) encoding proteins that are tightly related to amyloid-beta peptide metabolism or signalling. Although these variants are individually rare and restricted to particular subgroups of patients, these findings support the causal role, in human pathology, of a set of genes coding for molecules suspected for a long time to modify A beta metabolism or signalling, and for which animal or cellular models have already been developed. European Journal of Human Genetics (2012) 20, 613-617; doi:10.1038/ejhg.2011.225; published online 14 December 2011
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据